News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

PrEP Data Links Anti-HIV Immune Response to Reduce Chance of Infection

June 23, 2015
Article

Research published in the Proceedings of the National Academy of Sciences found that some individuals exposed to HIV-1, but who remain uninfected, have a certain pattern of virus-specific immune responses that differentiated them from individuals who became infected. The findings build upon prior research by studying these responses in the context of a controlled clinical trial, examining a large number of subjects, and by having access to specimens saved before anyone was infected. In the future, this information could be used to assess HIV-1 infection risk or inform the design of a preventive HIV-1 vaccine.

This new research, co-authored by George Washington University (GW) researcher Douglas Nixon, MD, PhD, and colleagues at UCSF, USP in Brazil, and the Gladstone Institutes, looked at data from the Pre-exposure Prophylaxis Initiative (iPrEx) trial, the first randomized controlled trial of pre-exposure chemoprophylaxis (PrEP) in humans. Remaining specimens from the trial were used to test for naturally acquired or induced immunity to HIV-1 infection. Those who became infected typically lacked responses to two HIV-1 proteins. The finding suggests that such immune responses may play a role in blocking systemic infection after exposure to the virus.

“Research has shown that T-cell responses can be observed in virally exposed but uninfected persons,” says Nixon, chair of the Department of Microbiology, Immunology & Tropical Medicine and Walter G. Ross Professor of Basic Science Research at the GW School of Medicine and Health Sciences. “The question that has remained unanswered is whether or not these T-cell responses could be protecting people from acquiring systemic HIV infection. The rigor of the placebo-controlled iPrEx trial gave us access to the necessary data and specimens to address that question. What we found was what people have been looking for, for a long time – a correlation between future infection risk and a measureable immune response.”

Using samples from the iPrEx trial, the research team compared immune responses mounted against an array of HIV-1 antigens by peripheral blood mononuclear cell samples: 84 samples were collected prior to infection from men who became HIV-positive and 480 samples from men who remained HIV-negative throughout the trial, including those who received the drug or placebo. T-cell responses against certain HIV-1 antigens were significantly higher and more frequent among those who remained uninfected compared with those who became HIV-positive, and these responses were associated with reduced risk of infection.

“The iPrEX trial showed that pre-exposure prophylaxis (or PrEP) with emtricitabine and tenofovir disoproxil fumarate (brand name Truvada in the United States) was highly effective for HIV prevention when used,” said Dr. Robert Grant, of the Gladstone Institutes, the protocol chair of iPrEx which was sponsored by the National Institutes of Health. “Whether taking drug or placebo, the observed immune responses were still present, so the protective benefit we saw with PrEP was not due to these immune responses. The discovery that cellular immunity correlates with HIV infection risk is a distinct and very exciting one. I hope it will provide clues leading to an HIV vaccine.”

“Demonstrating HIV protection associated with vaccine or, as in this case, exposure-induced immunity is a very high bar to achieve, and appropriately so. Our findings indicate that the host immune system interfaces with the virus or its proteins more commonly than previously thought, generating naturally induced immunity in the form of T-cell responses that contribute to a persistent HIV negative status in some exposed people. Only with additional research can we truly know if these immune responses can be induced by a vaccine candidate, and whether vaccine-induced responses provide protection,” according to Dr. Esper Kallas, of USP, co-senior author of the manuscript.

“A safe, effective, and easily administered preventative HIV vaccine is still needed and remains an important public health goal. HIV’s interaction with the human immune system is complex, therefore success with a vaccine is hard to predict. Nevertheless, the possibility that T-cell immunity, in addition to antibody-derived immunity, may contribute to protection is quite promising. The more ‘shots on goal’ we can take in a given vaccine, the more likely we are to succeed at preventing infection, and perhaps most importantly eventual eradication of HIV,” says lead author Dr. Peter Kuebler.

Peter Kuebler, of the Division of Experimental Medicine at UC San Francisco, is the first author of this study. Along with Nixon and Grant, Esper Kallas, of the Division of Clinical Immunology and Allergy at the University of Sao Paulo in Sao Paulo, Brazil, are co-senior authors.

The article, “Cellular Immune Correlates Analysis of an HIV-1 Pre-exposure Prophylaxis Trial,” is available at http://www.pnas.org/content/early/2015/06/17/1501443112.abstract.

Source: George Washington University 

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Subscribe Now!
Recent Videos
Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.  (Adobe Stock 1521632893 by Maksim)
From Awareness to Action: Educating Staff on Sharps Safety Standards
Amanda Heitman, BSN, RN, CNOR (Photo courtesy of Amanda Heitman)
Championing Surgical Safety: A Perioperative Nurse’s Perspective on Infection Prevention
Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.  (Adobe Stock 1521632893 by Maksim)
Sharps Safety Starts With Communication, Not Just Devices
DJ Shannon, MPH, CIC, VA-BC, FAPIC
All About APIC’s New Guide That Tackles All Catheter-Associated Bloodstream Infections
Jordan Bastian, MPH, CIC, at APIC25
Germs in the Halls: Why Infection Preventionists Are Going Back to School
Jordan Bastian, MPH, CIC, at APIC25
Keeping Classrooms Cleaner: Infection Preventionists Step into Schools
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Tried and True Infection Prevention Measures
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Why All This Viral Activity?
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mycoplasma Pneumoniae: Bacteria-Caused Respiratory Tract Infections
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Common Cold Symptoms and Statistics
Related Content
Advertisement

Cori L. Ofstead, MSPH; Brandon M. Gantt, MHA, CRCST, CHL, CER, LSSGBH; and Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL, an infection preventionist in Atlanta, Georgia.

Better Alerts, Better Cleaning: Why IFU Updates and Borescope Protocols Must Be Built Into SPD Workflows

Tori Whitacre Martonicz
July 24th 2025
Article

Sterile processing departments are facing a new standard: clean is not clean unless you can see it. At HSPA 2025, experts emphasized that updated IFUs and borescope inspections must be built into routine workflows, not as extra tasks, but as core components of quality control and infection prevention.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.  (Adobe Stock 1521632893 by Maksim)

Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done

Tori Whitacre Martonicz
Published: July 24th 2025 | Updated: July 23rd 2025
Podcast

Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.


UNESCO sign in Juodkrante, Lithuania (Adobe Stock by BOOCYS)

US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science

Infection Control Today® Editorial Staff
July 22nd 2025
Article

In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.


Pathogen Pulse

Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More

Tori Whitacre Martonicz
July 22nd 2025
Article

From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.


A mother and child having online telemedicine consultation with remote doctor about cold and flu virus treatment.  (Adobe Stock 479767497 Studio Romantic)

Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management

Stephan Hawke
July 22nd 2025
Article

In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste. (Adobe Stock 1521632893 by Maksim)

Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported

Tori Whitacre Martonicz
July 18th 2025
Article

Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.

Related Content
Advertisement

Cori L. Ofstead, MSPH; Brandon M. Gantt, MHA, CRCST, CHL, CER, LSSGBH; and Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL, an infection preventionist in Atlanta, Georgia.

Better Alerts, Better Cleaning: Why IFU Updates and Borescope Protocols Must Be Built Into SPD Workflows

Tori Whitacre Martonicz
July 24th 2025
Article

Sterile processing departments are facing a new standard: clean is not clean unless you can see it. At HSPA 2025, experts emphasized that updated IFUs and borescope inspections must be built into routine workflows, not as extra tasks, but as core components of quality control and infection prevention.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste.  (Adobe Stock 1521632893 by Maksim)

Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done

Tori Whitacre Martonicz
Published: July 24th 2025 | Updated: July 23rd 2025
Podcast

Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.


UNESCO sign in Juodkrante, Lithuania (Adobe Stock by BOOCYS)

US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science

Infection Control Today® Editorial Staff
July 22nd 2025
Article

In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.


Pathogen Pulse

Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More

Tori Whitacre Martonicz
July 22nd 2025
Article

From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.


A mother and child having online telemedicine consultation with remote doctor about cold and flu virus treatment.  (Adobe Stock 479767497 Studio Romantic)

Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management

Stephan Hawke
July 22nd 2025
Article

In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.


Set of bright yellow sharps containers with biohazard labels and red lids used in clinics and hospitals for safe disposal of medical needles and waste. (Adobe Stock 1521632893 by Maksim)

Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported

Tori Whitacre Martonicz
July 18th 2025
Article

Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.

Advertisement
Advertisement
Advertisement
x
Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News